Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 77, Issue 12
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Tuberculosis
Original research
High-dose rifamycins in the treatment of TB: a systematic review and meta-analysis
Online download statistics by month:
Online download statistics by month: January 2022 to February 2023
Abstract
Full
Pdf
Jan 2022
1803
162
81
Feb 2022
1054
63
43
Mar 2022
474
22
16
Apr 2022
387
13
10
May 2022
410
20
13
Jun 2022
246
8
2
Jul 2022
381
23
4
Aug 2022
313
10
12
Sep 2022
314
15
11
Oct 2022
280
18
16
Nov 2022
1542
66
41
Dec 2022
406
38
27
Jan 2023
147
24
13
Feb 2023
242
14
13
Total
7999
496
302
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF